BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27340749)

  • 21. Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation.
    Aldosari MH; de Vries RP; Rodriguez LR; Hesen NA; Beztsinna N; van Kuilenburg ABP; Hollak CEM; Schellekens H; Mastrobattista E
    Eur J Pharm Biopharm; 2019 Apr; 137():185-195. PubMed ID: 30818011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare Service Use Patterns Among Patients with Acid Sphingomyelinase Deficiency Type B: A Retrospective US Claims Analysis.
    Pulikottil-Jacob R; Ganz ML; Fournier M; Petruski-Ivleva N
    Adv Ther; 2023 May; 40(5):2234-2248. PubMed ID: 36897522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.
    Hollak CE; de Sonnaville ES; Cassiman D; Linthorst GE; Groener JE; Morava E; Wevers RA; Mannens M; Aerts JM; Meersseman W; Akkerman E; Niezen-Koning KE; Mulder MF; Visser G; Wijburg FA; Lefeber D; Poorthuis BJ
    Mol Genet Metab; 2012 Nov; 107(3):526-33. PubMed ID: 22818240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases.
    Cassiman D; Packman S; Bembi B; Turkia HB; Al-Sayed M; Schiff M; Imrie J; Mabe P; Takahashi T; Mengel KE; Giugliani R; Cox GF
    Mol Genet Metab; 2016 Jul; 118(3):206-213. PubMed ID: 27198631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiency.
    Halseth TA; Correia AB; Schultz ML; Fawaz MV; Kuiper EQ; Kumaran P; Dorsey KH; Schuchman EH; Lieberman AP; Schwendeman A
    Nanomedicine; 2023 Sep; 53():102705. PubMed ID: 37633404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
    Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
    Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
    Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).
    Wasserstein M; Dionisi-Vici C; Giugliani R; Hwu WL; Lidove O; Lukacs Z; Mengel E; Mistry PK; Schuchman EH; McGovern M
    Mol Genet Metab; 2019 Feb; 126(2):98-105. PubMed ID: 30514648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency.
    Gaudioso Á; Moreno-Huguet P; Casas J; Schuchman EH; Ledesma MD
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid Sphingomyelinase Deficiency: Sharing Experience of Disease Monitoring and Severity in France.
    Mauhin W; Borie R; Dalbies F; Douillard C; Guffon N; Lavigne C; Lidove O; Brassier A
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice.
    Garnacho C; Dhami R; Solomon M; Schuchman EH; Muro S
    Mol Ther; 2017 Jul; 25(7):1686-1696. PubMed ID: 28606376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis.
    Cappellini MD; Motta I; Barbato A; Giuffrida G; Manna R; Carubbi F; Giona F
    Eur J Intern Med; 2023 Feb; 108():81-84. PubMed ID: 36443133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid Sphingomyelinase Deficiency Type B Patient-Derived Liver Organoids Reveals Altered Lysosomal Gene Expression and Lipid Homeostasis.
    Gomez-Mariano G; Perez-Luz S; Ramos-Del Saz S; Matamala N; Hernandez-SanMiguel E; Fernandez-Prieto M; Gil-Martin S; Justo I; Marcacuzco A; Martinez-Delgado B
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A.
    Gabandé-Rodríguez E; Boya P; Labrador V; Dotti CG; Ledesma MD
    Cell Death Differ; 2014 Jun; 21(6):864-75. PubMed ID: 24488099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of lysosphingomyelin and lysosphingomyelin-509 for the screening of acid sphingomyelinase deficiency.
    Kubaski F; Burlina A; Pereira D; Silva C; Herbst ZM; Trapp FB; Michelin-Tirelli K; Lopes FF; Burin MG; Brusius-Facchin AC; Netto ABO; Poletto E; Bernardes TM; Carvalho GS; Sorte NB; Ferreira FN; Perin N; Clivati MR; de Santana MTS; Lobos SFG; Leão EKEA; Coutinho MP; Pinos PV; Santos MLSF; Penatti DA; Lourenço CM; Polo G; Giugliani R
    Orphanet J Rare Dis; 2022 Nov; 17(1):407. PubMed ID: 36348386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
    Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.
    Zhou YF; Metcalf MC; Garman SC; Edmunds T; Qiu H; Wei RR
    Nat Commun; 2016 Oct; 7():13082. PubMed ID: 27725636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic visceral acid sphingomyelinase deficiency (Niemann-Pick disease type B) in 16 Polish patients: long-term follow-up.
    Lipiński P; Kuchar L; Zakharova EY; Baydakova GV; Ługowska A; Tylki-Szymańska A
    Orphanet J Rare Dis; 2019 Feb; 14(1):55. PubMed ID: 30795770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann-Pick Disease: A Comprehensive Review.
    Tirelli C; Rondinone O; Italia M; Mira S; Belmonte LA; De Grassi M; Guido G; Maggioni S; Mondoni M; Miozzo MR; Centanni S
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases].
    Lidove O; Belmatoug N; Froissart R; Lavigne C; Durieu I; Mazodier K; Serratrice C; Douillard C; Goizet C; Cathebras P; Besson G; Amoura Z; Tazi A; Gatfossé M; Rivière S; Sené T; Vanier MT; Ziza JM
    Rev Med Interne; 2017 May; 38(5):291-299. PubMed ID: 27884455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.